From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing
Update: 2024-08-12
Description
In this edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH).
The wide-ranging interview tackles all aspects of Alzheimer’s testing and treatment, including:
- Why traditional methods of Alzheimer’s testing are expensive, invasive, and limit access.
- The benefits of blood-based biomarkers for Alzheimer’s diagnosis.
- How better diagnostics will benefit patients.
- Why we’re on the cusp of a new golden age of neurology
- How more biomarkers fuel not only better diagnostics but better treatments.
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
